DKK3 and Nephropathy: Interest in DKK3 as a urinary biomarker has risen after a study by Federico et al., where the authors showed that the inhibition of DKK3 in mice led to reduced kidney fibrosis and that the urinary DKK3 levels were increased in patients with higher levels of interstitial fibrosis and tubular atrophy, possibly reflecting kidney damage [17].